Cigna Corporation (CI) Insider Michael W. Triplett Sells 10,417 Shares
Cigna Corporation (NYSE:CI) insider Michael W. Triplett sold 10,417 shares of the stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $197.77, for a total transaction of $2,060,170.09. Following the transaction, the insider now directly owns 32,347 shares of the company’s stock, valued at $6,397,266.19. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Cigna Corporation (NYSE CI) traded up $4.47 during trading on Friday, reaching $200.97. 1,130,000 shares of the company traded hands, compared to its average volume of 1,360,139. Cigna Corporation has a 12-month low of $131.03 and a 12-month high of $206.45. The stock has a market cap of $48,820.00, a P/E ratio of 18.93, a price-to-earnings-growth ratio of 1.50 and a beta of 0.49. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.39 and a quick ratio of 0.39.
Cigna Corporation (NYSE:CI) last released its quarterly earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.36 by $0.47. Cigna Corporation had a net margin of 5.74% and a return on equity of 18.85%. The firm had revenue of $10.38 billion for the quarter, compared to the consensus estimate of $10.17 billion. During the same quarter in the previous year, the firm posted $1.94 EPS. The firm’s quarterly revenue was up 5.1% on a year-over-year basis. sell-side analysts predict that Cigna Corporation will post 10.34 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/11/17/cigna-corporation-ci-insider-michael-w-triplett-sells-10417-shares.html.
A number of hedge funds have recently made changes to their positions in the business. Wetherby Asset Management Inc. boosted its holdings in shares of Cigna Corporation by 0.8% in the 2nd quarter. Wetherby Asset Management Inc. now owns 4,192 shares of the health services provider’s stock valued at $702,000 after buying an additional 33 shares during the period. Cadence Capital Management LLC raised its position in shares of Cigna Corporation by 0.3% during the 2nd quarter. Cadence Capital Management LLC now owns 9,598 shares of the health services provider’s stock worth $1,607,000 after buying an additional 33 shares in the last quarter. Winslow Evans & Crocker Inc. raised its position in shares of Cigna Corporation by 1.9% during the 2nd quarter. Winslow Evans & Crocker Inc. now owns 1,814 shares of the health services provider’s stock worth $304,000 after buying an additional 34 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its position in shares of Cigna Corporation by 2.3% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,760 shares of the health services provider’s stock worth $295,000 after buying an additional 40 shares in the last quarter. Finally, Veritable L.P. raised its holdings in shares of Cigna Corporation by 0.5% in the 2nd quarter. Veritable L.P. now owns 8,220 shares of the health services provider’s stock worth $1,376,000 after purchasing an additional 41 shares in the last quarter. 89.69% of the stock is owned by institutional investors.
Several research firms recently issued reports on CI. Morgan Stanley increased their price target on shares of Cigna Corporation from $195.00 to $223.00 and gave the stock an “overweight” rating in a report on Friday, November 3rd. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $220.00 price target (up previously from $185.00) on shares of Cigna Corporation in a research note on Friday, November 3rd. ValuEngine downgraded shares of Cigna Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 20th. Citigroup Inc. increased their price target on shares of Cigna Corporation from $185.00 to $198.00 and gave the stock a “buy” rating in a research note on Monday, August 7th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a $190.00 price target (down previously from $199.00) on shares of Cigna Corporation in a research note on Friday, August 4th. Three equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Buy” and an average target price of $201.50.
Cigna Corporation Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.